The method of treatment of inflammatory processes


(57) Abstract:

Usage: in medicine, refers to methods for treating various inflammatory processes. The inventive method of treatment is that in addition to NSAIDs or glucocorticoids, appoint antidiabetics - biguanides. This method of treatment can be applied in the treatment of various inflammatory diseases: radiculitis, myositis, myocarditis, polyarthritis, collagen.

The invention relates to medicine, namely to methods for treating various inflammatory processes.

In medical practice, the number of known methods of treatment of inflammation with non-steroidal anti-inflammatory drugs (Mashkovsky M. D. Medicines, 1987, I. 1, pp. 187-202, 566-577). The disadvantage of these treatments is often noted low efficacy or lack of efficacy in the treatment of inflammatory diseases.

The aim of the invention is to accelerate anti-inflammatory effect in the treatment of patients with inflammatory process.

The essence of the proposed technical solution is, h is ecogov appoint a biguanide - antidiabetics in the usual therapeutic doses approved by farmkomiteta. This allows to significantly accelerate and enhance the anti-inflammatory effect in the body compared to previously used drugs.

Anti-inflammatory effect from the first day from the start of the reception of patients, which has not previously been the effect of the drugs listed in the prototype.

The decision about the appropriateness of technical solutions have emerged based on the fact that anti-inflammatory drugs lose their effectiveness when insulin is compromised (which is very well demonstrated in decompensated diabetes mellitus type I, but restore its efficiency at full compensation of diabetes insulin).

It is therefore proposed for the treatment of inflammatory processes in the body combined application of previously known anti-inflammatory drugs (described in the prototype), and medications group of biguanides, improves insulin security, by neutralizing kontrinsuljarnye of Titel, improve the sensitivity of tissue cell receptors to insulin, reduce blood cholesterol, which reduces the phagocytic function of whether the Lin - the activator of the immune system.

Contraindications - correspond to those specified in the annotation, approved Farmkomiteta.

The combined effective use of drugs conducted in 20 patients with inflammatory processes in the body, when the prototype was not given effect.


Patient R., 48 years old, diagnosis: rheumatoid arthritis, worsening.

Sick 3 years. Recent exacerbation of 1 month. Pain and swelling interphalangeal and large joints of the extremities. The temperature of 37.6oC. Treatment within 2 weeks of prednisolone at a dose of 20 mg per day effect is not given. The concomitant use of prednisone 20 mg and glibutida 1 t 2 p/d steadily shone with pain and swelling of the joints. Temperature 36,6oC in the blood count erythrocyte sedimentation rate decreased from 50 to 23 mm/h, CRP++++.

2. Patient S., 35 years old, diagnosis: bronchial asthma, infectious-allergic. Chronic bronchitis, aggravation.

Sick 5 years. Deterioration 1 month - daily asthma with difficult access, cough. Use within 3 weeks of prednisolone 15 mg daily effect is not given. The concomitant use of prednisone 15 mg per day, Adelita 1 t 2 p/d off asthma attacks in 1 day. In the analysis of blood ESR reduced">

Sick 2 years. Exacerbation of the disease 1 month. Temperature - 38oC, epigastric pain shingles character daily. The use of indomethacin on 1 t 3 R/d within 5 days effect on gave. The combined use of indomethacin 1 t 3 p/d and glibutida 1 t 2 p/d for one night - shot of pain, temperature 36,6oC ESR in blood decreased from 35 to 20 mm/h

The proposed solution may have wide application in various inflammatory diseases, acute and chronic: radiculitis, myositis, myocarditis, polyarthritis, collagen and many others.

The method of treatment of inflammatory processes, including the use of nonsteroidal means or glucorticoids, characterized in that it further designate the biguanides.


Same patents:

The invention relates to veterinary medicine, and in particular to methods of prevention of disease of young pigs
The invention relates to medicine, namely to anesthesiology
The invention relates to medicine, namely to anesthesiology

The invention relates to farming, in particular to the cultivation of downhole young foxes, and can be used in fur farms

The invention relates to medicines used in veterinary practice, and can be used in the production of veterinary drugs for the prevention and treatment of postpartum endometritis in cows
The invention relates to medicines used in veterinary practice for the treatment and prevention of diseases of viral and bacterial origin in farm animals and birds, in particular for the prevention and treatment of parainfluenza and rhinotracheitis in calves, dyspepsia, hepatobilary and malnutrition in piglets and infectious-inflammatory diseases of poultry

FIELD: veterinary science.

SUBSTANCE: a sow should be twice injected with oxytocin and, additionally, intramuscularly about 2-4 h after afterbirth detachment one should introduce clathroprostin at the dosage of 1 ml. The innovation suggested is very efficient in preventing metritis-mastitis-agalactia and endometritis in sows, as well.

EFFECT: higher efficiency of prophylaxis.

1 ex, 1 tbl

FIELD: medicine, in particular ophthalmology.

SUBSTANCE: claimed composition contains (mass %): antiviral drug 0.001-5; vegetable and/or animal phospholipids 0.001-2; sodium chloride 0.8-0.9; sodium hydrophosphate 0.001-0.2; sodium dihydrophosphate 0.001-0.2; and balance: distilled water.

EFFECT: composition with prolonged and effective action.

3 ex

FIELD: medicine, pharmacy.

SUBSTANCE: invention relates to a pharmaceutical composition that comprises internal lipophilic matrix and external hydrophilic matrix in the mass ratio of lipophilic and hydrophilic matrices from 100:0.5 to 100:20. The internal lipophilic matrix consists of substances with melting point below 90oC and comprises at least partially an active component as globules. As an active component the composition comprises mesalazine - 5-aminosalicylic acid in the concentration up to 95 wt.-%. Lipophilic matrix is dispersed in external hydrophilic matrix. The composition can comprise optionally other excipients. Also, invention describes a method for preparing the composition. Invention provides sustained-release of mesalazine from first phases after administration and more homogenous pattern of release as compared with conventional systems.

EFFECT: improved properties of composition.

11 cl, 5 ex

FIELD: veterinary science.

SUBSTANCE: one should introduce mineral additives into the diet of animals in postoperational period for 15-17 d at 4.0-5.0 g, zinc sulfate 0.75-1.5 g, cobalt chloride 30-35 mg, manganese sulfate 40-45 mg, potassium iodide 10-15 mg, monopotassium phosphate 80-100 per 100 kg body weight, moreover, elemental sulfur and monocalcium phosphate should be introduced in combination with concentrates, and zinc sulfate, cobalt chloride, manganese sulfate and potassium iodide should be introduced in dissolved form in the mixture with feedstuffs. The present method enables to decrease the terms for wounds healing.

EFFECT: higher efficiency.

3 tbl

FIELD: medicine.

SUBSTANCE: method involves clearing dental deposit from teeth. Biopolymer film is applied upon dental surface and marginal part of gingiva for 6-8 h. The film is manufactured from a combination of hydrophobic and hydrophilic layers containing sodium chloride and chlorhexidine bigluconate. The total treatment course containing one daily application is 7-10 days long. The course is repeated in 3-4 weeks.

EFFECT: enhanced effectiveness of prophylactic treatment.

2 tbl

FIELD: medicine.

SUBSTANCE: before applying substitute hormonal therapy (SHT) on should evaluate antithrombogenic activity of vascular wall in women. For this purpose one should determine quantitative values of ADP-induced aggregation of thrombocytes, activity of antithrombin III in blood and fibrinolytic blood activity both before and after "cuff"-test. Then one should detect the indices calculated as the ratio of mentioned values both before and after carrying out the mentioned test. If mentioned indices are decreased against the norm by 20-40% women should be prescribed to undergo SHT at additional introduction of aspirin and supradin. The method provides prophylaxis of cardio-vascular diseases in this category of female patients due to correcting affected functional activity of vascular endothelium.

EFFECT: higher efficiency of prophylaxis.

1 cl, 1 ex, 4 tbl

FIELD: veterinary science.

SUBSTANCE: the method deals with injecting oxylate once daily for 3 d at the dosage of 1 ml/30 kg body weight at repeated therapy course in 5 d at the background of antibioticotherapy. The method enables to normalize biochemical and morphological blood values and increase average daily body weight gain in sick animals.

EFFECT: higher efficiency of therapy.

2 ex, 2 tbl

FIELD: medicine, toxicology.

SUBSTANCE: the present innovation deals with the ways to inhibit toxins in animals and people in case of gastro-intestinal tract (GIT) disease. One should introduce therapeutically efficient quantity of polymer that has several lateral acidic functional groups attached directly to the main chain of polymer or being connected with it due to intermediate group. The latter could have the chain of 0-20 atoms length. Toxin is usually being exotoxin secreted by pathogenic microorganisms, such as bacteria, for example in case of diarrhea. The method enables to widen the quantity of preparations applied in case of bacterial GIT lesions.

EFFECT: higher efficiency.

39 cl, 2 dwg, 23 ex, 1 tbl

FIELD: medicine.

SUBSTANCE: method involves introducing cauterizing necrotizing composition like paste containing silver nitrate and dextrane into uterine cavity. Paste contact to target tissue is supported during time enough for reaching chemical necrosis. Then cauterizing composition is brought in contact with deactivating agent like aqueous solution of sodium chloride and removed from the uterine cavity later on. It is proposed to protect non-target tissue by supplying protection agent to it and carrying out previously described steps.

EFFECT: enhanced effectiveness of cauterization controlled in time and action intensity degree; avoided other tissue injuries.

30 cl, 8 dwg

FIELD: pharmaceutical industry.

SUBSTANCE: cyclic glycerophosphates and their analogues were shown to produce neural activation effect in target cells. Such effect includes activation of penetration of neurons, activation of neuron growth, providing dopaminotropic supporting medium in damaged part of brain, preventing degeneration of nerves, and salvation of nerves. Such activity of glycerophosphates and their analogues makes them useful in treatment of patients with various disorders including, but not limited to, psychic troubles such as. for example, schizophrenia, imbecility, or disorders leading to incapacity of being educated. Drugs can be further for treating neurodegenerative conditions such as Alzheimer disease, Parkinson disease, conditions caused by harmful environmental effects or mechanical injuries.

EFFECT: expanded possibilities for treatment of patient suffered from a primary neurodegenerative condition, for prevention or alleviation of manifestations of a secondary degeneration in new nerves (salvation of nerves).

36 cl, 4 dwg, 1 tbl, 19 ex